BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1827448)

  • 1. Mass spectrometric and high-performance liquid chromatographic studies of medroxyprogesterone acetate metabolites in human plasma.
    Sturm G; Häberlein H; Bauer T; Plaum T; Stalker DJ
    J Chromatogr; 1991 Jan; 562(1-2):351-62. PubMed ID: 1827448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simple high-performance liquid chromatographic method for the determination of medroxyprogesterone acetate in human plasma.
    Read J; Mould G; Stevenson D
    J Chromatogr; 1985 Jun; 341(2):437-44. PubMed ID: 3161906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific and sensitive determination of medroxyprogesterone acetate in human serum by gas chromatography-mass spectrometry.
    Dikkeschei LD; van Veelen H; Nagel GT; Willemse PH; Wolthers BG
    J Chromatogr; 1985 Nov; 345(1):1-10. PubMed ID: 2935550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative gas-liquid chromatographic determination of medroxyprogesterone acetate in human plasma.
    Rossi E; De Pascale A; Negrini P; Frigerio A; Castegnaro E; Castegnaro E
    J Chromatogr; 1979 Feb; 169():416-21. PubMed ID: 536431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medroxyprogesterone acetate does not perturb the profile of steroid metabolites in urine during pregnancy.
    Yovich JL; Willcox DL; Wilkinson SP; Poletti VM; Hähnel R
    J Endocrinol; 1985 Mar; 104(3):453-9. PubMed ID: 3156203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of illegal medroxyprogesterone acetate-application in veal calves by residue analysis in adipose tissue using HPLC/RIA methods.
    Rapp M; Meyer HH
    Food Addit Contam; 1989; 6(1):59-69. PubMed ID: 2521473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of mass spectrometry and radioimmunoassay to measure medroxyprogesterone acetate in patients with endometrial cancer.
    Kärkkäinen J; Vesterinen E; Stenman UH; Adlercreutz H; Nieminen U; Widholm O
    Eur J Cancer; 1990; 26(9):975-7. PubMed ID: 2149024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative determination of medroxyprogesterone acetate in plasma by liquid chromatography/electrospray ion trap mass spectrometry.
    Kim SM; Kim DH
    Rapid Commun Mass Spectrom; 2001; 15(21):2041-5. PubMed ID: 11675672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific quantitation of plasma medroxyprogesterone acetate by gas chromatography/mass spectrometry.
    Phillipou G; Frith RG
    Clin Chim Acta; 1980 Apr; 103(2):129-33. PubMed ID: 6445243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medroxyprogesterone acetate in human serum.
    Mathrubutham M; Fotherby K
    J Steroid Biochem; 1981 Aug; 14(8):783-6. PubMed ID: 6457936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific and sensitive quantitation of medroxyprogesterone acetate in human serum by gas chromatography-mass spectrometry.
    Järvinen T; Keinonen T; Auriola S; Peura P; Hirvonen E; Palva E
    J Chromatogr; 1989 Oct; 495():13-20. PubMed ID: 2533215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and partial synthesis of a new metabolite of medroxyrogesterone acetate.
    Fukushima DK; levin J; Liang JS; Smulowitz M
    Steroids; 1979 Jul; 34(1):57-72. PubMed ID: 483336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ring-A reduction of medroxyprogesterone acetate [17 alpha-acetoxy-6 alpha-methyl-4-pregnene-3,20-dione (MPA)] in biological systems.
    Martin F; Järvenpää P; Kosunen K; Somers C; Lindstrom B; Adlercreutz H
    J Steroid Biochem; 1980 Jan; 12():491-7. PubMed ID: 6448323
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacokinetics and pharmacodynamics of medroxyprogesterone acetate in advanced breast cancer patients.
    Etienne MC; Milano G; Frenay M; Renee N; Francois E; Thyss A; Schneider M; Namer M
    J Clin Oncol; 1992 Jul; 10(7):1176-82. PubMed ID: 1535103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of gestagens in kidney fat by liquid chromatography tandem mass spectrometry.
    Lõhmus M; Kender T
    Anal Chim Acta; 2007 Mar; 586(1-2):233-8. PubMed ID: 17386717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism of medroxyprogesterone acetate and hepatic drug metabolism activity.
    Rautio A; Saarni HU; Arranto AJ; Stengård JH; Kärki NT; Sotaniemi EA
    Res Commun Chem Pathol Pharmacol; 1985 Feb; 47(2):305-8. PubMed ID: 3158039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and metabolism of medroxyprogesterone acetate in patients with advanced breast cancer.
    Utaaker E; Lundgren S; Kvinnsland S; Aakvaag A
    J Steroid Biochem; 1988 Oct; 31(4A):437-41. PubMed ID: 2971841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-optic and hypothalamic neurons accumulate [3H]medroxyprogesterone acetate in male cynomolgus monkeys.
    Rees HD; Bonsall RW; Michael RP
    Life Sci; 1986 Oct; 39(15):1353-9. PubMed ID: 2945066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medroxyprogesterone acetate- and ethinylestradiol-induced changes in biliary bile acids of the rat studied by high-performance liquid chromatography.
    Baker PR; Vitale GC; Siow YF
    J Chromatogr; 1987 Dec; 423():63-73. PubMed ID: 2965158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MPA plasma levels after oral administration in gastrectomized cancer patients during chemotherapy.
    Fornasiero A; Daniele O; Fosser V; Morandi P; Fiorentino MV
    Chemioterapia; 1985 Jun; 4(3):256-9. PubMed ID: 3161644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.